Back to top
more

Axalta Coating Systems (AXTA)

(Delayed Data from NYSE)

$28.68 USD

28.68
2,985,159

+0.60 (2.14%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $28.68 0.00 (0.00%) 7:36 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 34% (163 out of 246)

Industry: Chemical - Specialty

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Axalta Coating Systems (AXTA) Reports Q2 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

While the top- and bottom-line numbers for Axalta Coating Systems (AXTA) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Axalta Coating Systems (AXTA) Q2 Earnings Beat Estimates

by Zacks Equity Research

Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of +4.92% and -1.33%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Quaker Chemical (KWR) Q2 Earnings Expected to Decline

by Zacks Equity Research

Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Axalta Coating Systems (AXTA) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Axalta Coating Systems (AXTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Axalta Coating Systems (AXTA) Reports Q1 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

The headline numbers for Axalta Coating Systems (AXTA) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Axalta Coating Systems (AXTA) Beats Q1 Earnings Estimates

by Zacks Equity Research

Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of 9.26% and 0.97%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Ecovyst (ECVT) Beats Q1 Earnings Estimates

by Zacks Equity Research

Ecovyst (ECVT) delivered earnings and revenue surprises of 133.33% and 6.29%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Axalta Coating Systems (AXTA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Axalta Coating Systems (AXTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Axalta Coating Systems (AXTA) Moves 11.5% Higher: Will This Strength Last?

by Zacks Equity Research

Axalta Coating Systems (AXTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Zacks Equity Research

Will Axalta Coating Systems (AXTA) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Axalta Coating Systems (AXTA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

BASF Unit Launches First Reduced Carbon Footprint Product

by Zacks Equity Research

BASFY reduces PCF by 10-15% in its newly launched rPCF aroma ingredients portfolio.

Zacks Equity Research

Best Growth Stocks to Buy for April 7th

by Zacks Equity Research

PBI, BJRI and AXTA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 7, 2025.

Zacks Equity Research

Barrick Gold Sets Target for 30% Production Growth by 2030

by Zacks Equity Research

GOLD is strategically enhancing its portfolio to drive sustainable production and profitable growth.

Zacks Equity Research

AXTA vs. HWKN: Which Stock Is the Better Value Option?

by Zacks Equity Research

AXTA vs. HWKN: Which Stock Is the Better Value Option?

Zacks Equity Research

BASF Expands Portfolio With Sustainable Personal Care Solutions

by Zacks Equity Research

BASFY launches personal care solutions as biodegradable alternatives to traditional products at in-cosmetics Global 2025 held in Amsterdam.

Zacks Equity Research

KWR Wraps Up Dipsol Chemicals Buyout & Announces Natech Acquisition

by Zacks Equity Research

Dipsol and Natech strengthen Quaker Chemical's position in their respective markets and product technologies.

Zacks Equity Research

LYB Joins Nexeo to Distribute Engineered Polymer Portfolio in Europe

by Zacks Equity Research

LyondellBasell provides a wide variety of compounds based on polyamides, polyesters and blends, among others.

Zacks Equity Research

Ashland Wraps Up Expansion of Pharmaceutical Plant in Brazil

by Zacks Equity Research

ASH is investing in modernizing equipment for microbial protection in personal care applications at its Technical Center in Sao Paulo.

Zacks Equity Research

GrowGeneration Expands Digital Capabilities With B2B Pro Portal Launch

by Zacks Equity Research

GRWG launches advanced B2B Pro Portal, which is designed to streamline purchasing for commercial cultivators and retailers.

Zacks Equity Research

Zacks.com featured highlights include EmbraerEmpresa Brasileira de Aeronautica, Steelcase and Axalta Coating Systems

by Zacks Equity Research

EmbraerEmpresa Brasileira de Aeronautica, Steelcase and Axalta Coating Systems are part of the Zacks Screen of the Week article.

Zacks Equity Research

DuPont Introduces Liveo Pharma TPE Ultra-Low Temp Tubing

by Zacks Equity Research

DD brings Liveo Pharma TPE Ultra-Low Temp Tubing into the market for biopharmaceutical processing applications.

Zacks Equity Research

Here's Why You Should Retain Albemarle Stock in Your Portfolio

by Zacks Equity Research

ALB gains on actions to boost its lithium conversion capacity and productivity actions amid headwinds from softer lithium prices.

Zacks Equity Research

Here's Why You Should Add Ingevity Stock to Your Portfolio

by Zacks Equity Research

NGVT benefits from the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.

Zacks Equity Research

FMC & Bayer Partner to Bring Isoflex Active to European Markets

by Zacks Equity Research

FMC signed a partnership agreement to bring Isoflex Active technology to European markets.

Zacks Equity Research

Ero Copper Extends Deal With Royal Gold to Boost Growth at Xavantina

by Zacks Equity Research

ERO secures a $50-million precious metals purchase agreement with Royal Gold related to the Xavantina operations.